Hematologic Malignancies Market Size, Analysis, Statics trends
The Global Hematologic Malignancies Market Size is Anticipated to Exceed USD 144.58 Billion by 2033, Growing at a CAGR of 7.97% from 2023 to 2033. Hematologic malignancies are cancers of the blood-producing cells, including multiple myeloma, leukemia, and lymphoma. The bone marrow produces hematopoietic stem and progenitor cells, which give rise to platelets, red blood cells (RBCs), and white blood cells (WBCs). These cells are involved in oxygen delivery, wound clotting, and immunological defense.